Lucid Diagnostics Advances Multiple EsoGuard® and EsoCheck® Payment, Billing and Coding Pathways
A Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests recommended maintaining EsoGuard's original gapfill payment basis under the Clinical Laboratory Fee Schedule, and CMS has posted a consent agenda reflecting that recommendation with final determinations expected in November after a public comment period. Separately, the AMA CPT Editorial Panel approved a new Category III CPT code for reporting nonendoscopic esophageal cell collection performed with EsoCheck, giving physicians and health systems a billing pathway to track office-based collection procedures and their outcomes.
Key figures
- Pla code
- 0114U
- Cpt code type
- Category III CPT code for nonendoscopic esophageal cell collection (number pending publication)
- Proposed icd10 cm code
- R85.83
- Texas medicare claims start
- September 2026
- Cms final determination timing
- November, following public comment period
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.